These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23993432)

  • 1. Complicated Clostridium difficile colitis in children with cystic fibrosis: association with gastric acid suppression?
    Com G; Cetin N; O'Brien CE
    J Cyst Fibros; 2014 Jan; 13(1):37-42. PubMed ID: 23993432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.
    Hauben M; Horn S; Reich L; Younus M
    Int J Infect Dis; 2007 Sep; 11(5):417-22. PubMed ID: 17336566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
    Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
    J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
    Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
    JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to Gastric Acid-Suppression Therapy Is Associated With Health Care- and Community-Associated Clostridium difficile Infection in Children.
    Jimenez J; Drees M; Loveridge-Lenza B; Eppes S; delRosario F
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):208-11. PubMed ID: 25806678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Established and potential risk factors for Clostridum difficile infection.
    Vaishnavi C
    Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomembranous colitis in cystic fibrosis.
    Nagakumar P
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():26-7. PubMed ID: 23601208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation.
    Theunissen C; Knoop C; Nonhoff C; Byl B; Claus M; Liesnard C; Estenne MJ; Struelens MJ; Jacobs F
    Transpl Infect Dis; 2008 Jul; 10(4):240-4. PubMed ID: 17630999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.
    Yearsley KA; Gilby LJ; Ramadas AV; Kubiak EM; Fone DL; Allison MC
    Aliment Pharmacol Ther; 2006 Aug; 24(4):613-9. PubMed ID: 16907893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clostridium difficile infection in children--experience of clinical centre in Bydgoszcz].
    Duleba K; Smukalska E; Pawłowska M
    Przegl Epidemiol; 2012; 66(1):67-71. PubMed ID: 22708301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
    Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
    Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Clostridium difficile colitis in cystic fibrosis: an emerging problem.
    Egressy K; Jansen M; Meyer KC
    J Cyst Fibros; 2013 Jan; 12(1):92-6. PubMed ID: 22717532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile-related pancolitis in lung-transplanted patients with cystic fibrosis.
    Patriarchi F; Rolla M; Maccioni F; Menichella A; Scacchi C; Ambrosini A; Costantino A; Quattrucci S
    Clin Transplant; 2011; 25(1):E46-51. PubMed ID: 20642799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile colitis in children following lung transplantation.
    Rosen JB; Schecter MG; Heinle JS; McKenzie ED; Morales DL; Dishop MK; Danziger-Isakov L; Mallory GB; Elidemir O
    Pediatr Transplant; 2010 Aug; 14(5):651-6. PubMed ID: 20561346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic megacolon after abdominoplasty: a case report.
    Wade JW
    Ann Plast Surg; 2014; 72(6):S170-1. PubMed ID: 24667886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.